JP2015521630A - 頭痛の頻度および／または重症度を下げるための組成物および方法 - Google Patents

頭痛の頻度および／または重症度を下げるための組成物および方法 Download PDF

Info

Publication number
JP2015521630A
JP2015521630A JP2015518721A JP2015518721A JP2015521630A JP 2015521630 A JP2015521630 A JP 2015521630A JP 2015518721 A JP2015518721 A JP 2015518721A JP 2015518721 A JP2015518721 A JP 2015518721A JP 2015521630 A JP2015521630 A JP 2015521630A
Authority
JP
Japan
Prior art keywords
adipose tissue
stromal
cells
headache
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015518721A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015521630A5 (enExample
Inventor
ラルフ ブライト
ラルフ ブライト
ペリン ブライト
ペリン ブライト
ブルース ハンセン
ブルース ハンセン
ウェイン トーマス
ウェイン トーマス
Original Assignee
ラスティー プロパティー ホールディングス プロプライエタリー リミテッド
ラスティー プロパティー ホールディングス プロプライエタリー リミテッド
アンバーデイル エンタープライゼズ プロプライエタリー リミテッド
アンバーデイル エンタープライゼズ プロプライエタリー リミテッド
タビッド プロプライエタリー リミテッド
タビッド プロプライエタリー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012902720A external-priority patent/AU2012902720A0/en
Application filed by ラスティー プロパティー ホールディングス プロプライエタリー リミテッド, ラスティー プロパティー ホールディングス プロプライエタリー リミテッド, アンバーデイル エンタープライゼズ プロプライエタリー リミテッド, アンバーデイル エンタープライゼズ プロプライエタリー リミテッド, タビッド プロプライエタリー リミテッド, タビッド プロプライエタリー リミテッド filed Critical ラスティー プロパティー ホールディングス プロプライエタリー リミテッド
Publication of JP2015521630A publication Critical patent/JP2015521630A/ja
Publication of JP2015521630A5 publication Critical patent/JP2015521630A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vascular Medicine (AREA)
JP2015518721A 2012-06-26 2013-06-26 頭痛の頻度および／または重症度を下げるための組成物および方法 Pending JP2015521630A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012902720A AU2012902720A0 (en) 2012-06-26 Compositions and methods for reducing frequency and/or severity of headache
AU2012902720 2012-06-26
PCT/AU2013/000684 WO2014000029A1 (en) 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache

Publications (2)

Publication Number Publication Date
JP2015521630A true JP2015521630A (ja) 2015-07-30
JP2015521630A5 JP2015521630A5 (enExample) 2016-08-04

Family

ID=49781943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015518721A Pending JP2015521630A (ja) 2012-06-26 2013-06-26 頭痛の頻度および／または重症度を下げるための組成物および方法

Country Status (9)

Country Link
US (1) US10206956B2 (enExample)
EP (1) EP2863927A4 (enExample)
JP (1) JP2015521630A (enExample)
KR (1) KR20150091037A (enExample)
CN (1) CN104902909A (enExample)
AU (1) AU2013284338B2 (enExample)
CA (1) CA2877022A1 (enExample)
NZ (1) NZ703345A (enExample)
WO (1) WO2014000029A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
JP2019214534A (ja) * 2018-06-13 2019-12-19 株式会社 バイオミメティクスシンパシーズ モノアミン産生増加剤としての間葉系幹細胞を含む医薬組成物
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014179834A1 (en) * 2013-05-10 2014-11-13 Cell-Innovations Pty Ltd Compositions and methods for the treatment of tinnitus
AU2014284440B2 (en) * 2013-07-01 2018-07-19 Amit Prakash Govil Soft tissue implant
CN110772535A (zh) * 2018-07-12 2020-02-11 南通大学 多系分化持续应激细胞在制备镇痛药物中的应用
JP6497827B1 (ja) * 2018-07-17 2019-04-10 株式会社 バイオミメティクスシンパシーズ エイコサノイド産生促進剤
EP3847241A1 (en) 2018-10-26 2021-07-14 Stemselect Method and apparatus for mesenchymal stem cells isolation and purification
WO2022104069A1 (en) * 2020-11-13 2022-05-19 Advanced Therapeutic Lab, Inc. Therapeutic methods and compositions utilizing stromal vascular fraction derived from adipose tissue

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008194044A (ja) * 2001-11-09 2008-08-28 Artecel Sciences Inc 脂肪組織由来間質細胞の膵内分泌分化およびその使用
JP2010037292A (ja) * 2008-08-06 2010-02-18 Univ Of Tokyo 脂肪由来幹細胞と塩基性線維芽細胞増殖因子を組み合わせた線維性病変の治療法
WO2010127310A1 (en) * 2009-05-01 2010-11-04 Cytori Therapeutics, Inc. Systems, methods and compositions for optimizing tissue and cell enriched grafts
JP2011010581A (ja) * 2009-06-30 2011-01-20 Kaneka Corp 幹細胞分離材、幹細胞分離フィルター、及び該分離材または該分離フィルターを用いた幹細胞分離方法、幹細胞回収方法
JP2011068663A (ja) * 2003-08-07 2011-04-07 Healor Ltd 創傷治癒を促進するための薬剤組成物及び方法
JP2011078416A (ja) * 1999-03-10 2011-04-21 Univ Of Pittsburgh Of The Commonwealth System Of Higher Education 脂肪由来の幹細胞および格子
WO2011119829A1 (en) * 2010-03-24 2011-09-29 Lifenet Health Bmp-4 peptides & methods of use
WO2011138786A2 (en) * 2010-05-06 2011-11-10 Stem Cell Medicine Ltd. Stem cell bank for personalized medicine
JP2012500021A (ja) * 2008-08-20 2012-01-05 アンスロジェネシス コーポレーション 改良型細胞組成物およびその作製方法
JP2012080882A (ja) * 2003-10-08 2012-04-26 Vet-Stem Inc 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
US20120101479A1 (en) * 2009-04-30 2012-04-26 Bill Paspaliaris [methods and apparatuses for isolating and preparing stem cells]
JP2012100662A (ja) * 2011-12-05 2012-05-31 Sapporo Medical Univ 細胞増殖方法ならびに組織の修復および再生のための医薬
JP2012512909A (ja) * 2008-12-19 2012-06-07 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 神経因性疼痛および痙攣を治療するための臍帯組織由来細胞
WO2012083024A1 (en) * 2010-12-17 2012-06-21 Anthrogenesis Corporation Treatment of spinal cord injury and traumatic brain injury using placental stem cells
WO2012127320A1 (en) * 2011-03-22 2012-09-27 Pluristem Ltd. Methods for treating radiation or chemical injury

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2901136B1 (fr) * 2006-05-18 2010-10-01 Centre Nat Rech Scient Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral
JP5950577B2 (ja) * 2008-08-20 2016-07-13 アンスロジェネシス コーポレーション 単離胎盤細胞を使用した脳卒中の治療
NZ612801A (en) * 2010-12-27 2014-12-24 Intellicell Biosciences Inc Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
CN104220081A (zh) * 2011-06-01 2014-12-17 人类起源公司 利用胎盘干细胞治疗疼痛

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011078416A (ja) * 1999-03-10 2011-04-21 Univ Of Pittsburgh Of The Commonwealth System Of Higher Education 脂肪由来の幹細胞および格子
JP2008194044A (ja) * 2001-11-09 2008-08-28 Artecel Sciences Inc 脂肪組織由来間質細胞の膵内分泌分化およびその使用
JP2011068663A (ja) * 2003-08-07 2011-04-07 Healor Ltd 創傷治癒を促進するための薬剤組成物及び方法
JP2012080882A (ja) * 2003-10-08 2012-04-26 Vet-Stem Inc 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
JP2010037292A (ja) * 2008-08-06 2010-02-18 Univ Of Tokyo 脂肪由来幹細胞と塩基性線維芽細胞増殖因子を組み合わせた線維性病変の治療法
JP2012500021A (ja) * 2008-08-20 2012-01-05 アンスロジェネシス コーポレーション 改良型細胞組成物およびその作製方法
JP2012512909A (ja) * 2008-12-19 2012-06-07 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 神経因性疼痛および痙攣を治療するための臍帯組織由来細胞
US20120101479A1 (en) * 2009-04-30 2012-04-26 Bill Paspaliaris [methods and apparatuses for isolating and preparing stem cells]
WO2010127310A1 (en) * 2009-05-01 2010-11-04 Cytori Therapeutics, Inc. Systems, methods and compositions for optimizing tissue and cell enriched grafts
JP2011010581A (ja) * 2009-06-30 2011-01-20 Kaneka Corp 幹細胞分離材、幹細胞分離フィルター、及び該分離材または該分離フィルターを用いた幹細胞分離方法、幹細胞回収方法
WO2011119829A1 (en) * 2010-03-24 2011-09-29 Lifenet Health Bmp-4 peptides & methods of use
WO2011138786A2 (en) * 2010-05-06 2011-11-10 Stem Cell Medicine Ltd. Stem cell bank for personalized medicine
WO2012083024A1 (en) * 2010-12-17 2012-06-21 Anthrogenesis Corporation Treatment of spinal cord injury and traumatic brain injury using placental stem cells
WO2012127320A1 (en) * 2011-03-22 2012-09-27 Pluristem Ltd. Methods for treating radiation or chemical injury
JP2014508799A (ja) * 2011-03-22 2014-04-10 プルリステム リミテッド 放射線照射または化学物質による傷害を治療するための方法
JP2012100662A (ja) * 2011-12-05 2012-05-31 Sapporo Medical Univ 細胞増殖方法ならびに組織の修復および再生のための医薬

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
US12089944B2 (en) 2017-02-27 2024-09-17 Payman Sadeghi Method and system for neurohydrodissection
JP2019214534A (ja) * 2018-06-13 2019-12-19 株式会社 バイオミメティクスシンパシーズ モノアミン産生増加剤としての間葉系幹細胞を含む医薬組成物
WO2019240126A1 (ja) * 2018-06-13 2019-12-19 株式会社バイオミメティクスシンパシーズ モノアミン産生増加剤としての間葉系幹細胞を含む医薬組成物

Also Published As

Publication number Publication date
CA2877022A1 (en) 2014-01-03
CN104902909A (zh) 2015-09-09
US10206956B2 (en) 2019-02-19
EP2863927A1 (en) 2015-04-29
US20150174172A1 (en) 2015-06-25
NZ703345A (en) 2017-03-31
AU2013284338A1 (en) 2015-01-22
AU2013284338B2 (en) 2018-03-01
EP2863927A4 (en) 2015-12-02
KR20150091037A (ko) 2015-08-07
WO2014000029A1 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
US10206956B2 (en) Compositions and methods for reducing frequency and/or severity of headache
US11236324B2 (en) Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use
AU2011352928B2 (en) Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
CN108671224B (zh) 血小板裂解物的组合物、用途和制备
WO2011047345A2 (en) Methods of treating diseases of conditions using mesenchymal stem cells
TW201130977A (en) Mesenchymal stem cells (MSCs) isolated from mobilized peripheral blood
US20160120909A1 (en) Compositions And Methods For The Treatment Of Tinnitus
WO2014015229A1 (en) Isolation of stromal vascular fraction from adipose tissue obtained from postmortem source using ultrasonic cavitation
JPWO2014178438A1 (ja) 毛髪再生用の細胞製剤
CN108324992A (zh) 软骨修复用组合物及关节软骨的修复方法
US20240091269A1 (en) Treatment of bipolar disorder using mesenchymal stem cells and modification of mesenchymal stem cells
US20250066735A1 (en) Preparation method of mesenchymal stem cell (msc) and application thereof in knee product
Sultan Wharton’s Jelly Mesenchymal Stromal Cells to Improve Salivary Secretion in a Sjögren-like Disease Mouse Model
US20160051701A1 (en) Improved methods for osteoarthritis therapy
US20200038451A1 (en) Stem cells as an individualized maternal therapy for prevention of prematurity
KR20240136869A (ko) 조혈 줄기세포 증식 또는 가동화 촉진용 조성물 및 가동화 조혈 줄기세포 수집방법
Alfaifi Cell therapy for acute liver injury-in vivo efficacy of mesenchymal stromal cells in toxic and immune-mediated murine hepatitis
HK40082460A (en) Prophylactic and/or therapeutic agent for diabetes
WO2014047688A1 (en) Therapeutics using multiple injections of cells
CN110840914A (zh) 细胞治疗剂用于缓解或改善血管病变的方法

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160616

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170501

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170726

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180111